SCHEMBL19675604

SCHEMBL19675604

C/C=C\c1cnc(C)nc1/C=C\C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16442100 0.86 NOS2 (0.31) NOS2
SCHEMBL19308504 0.86 PDE10A (0.32) NOS2
SCHEMBL24466695 0.81 GRM4 (0.40) NOS2
SCHEMBL19835245 0.81 GRM4 (0.40) NOS2
SCHEMBL27772975 0.78 PDK2 (0.41)
SCHEMBL24165636 0.78 NOS2 (0.40) NOS2
SCHEMBL23978663 0.75 KDM5A (0.31)
SCHEMBL18597002 0.69 PDE10A (0.31)
SCHEMBL13348654 0.68 MEN1 (0.33)
SCHEMBL22002024 0.68 EGFR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-B1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2020-02-26 EP disclosed
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed